Pharmaceutical Network April 1st News Chinese Medicine Granules Field in the capital industry in the capital industry，Recently, there have been staged results。

 

March 30，China Traditional Chinese Medicine (00570.HK) issued an announcement name，The company has been on March 22 to the controlling stake sports betting appshareholder stake sports betting appChinese medicine、Singapore sovereign fund GIC、Everbright Paudexin、Huaxia Fund、China Life Insurance and other 25 institutional investors and 2 executive directors reached a related transaction with new shares，Glocked 7.2 billion Hong Kong dollars，This fund will be used to acquire 87.3%equity of Jiangyin Tianjiang Pharmaceutical。

 

As early as January this year，Hong Kong stock platforms under the National Medicine Group China Chinese Medicine will be suspended and prepared to acquire Tianjiang Pharmaceutical，With the finalization of the transaction，The final transaction price was between 8.1927 billion yuan (about HK $ 10.2 billion) to 8.946 billion yuan (about HK $ 11.2 billion)，Fundamental transactions also mentioned the schedule of discussion。

 

The final end of the acquisition of Tianjiang Pharmaceutical, a large factory of the Chinese Medicine Granules，It is also regarded as another improvement layout of the resource allocation of many of the listed companies in the Sinopharm Group。March 31，After the Chinese medicine resumes the trading of Chinese medicine, the red disk was opened，The stock price was closed at HK $ 5.26 that day，increased more than 10.04%。

 

stake betting appAs the National Administration stake sports betting appof Traditional Chinese Medicine, the first & ldquo; the pilot unit of the national Chinese medicine decoction film reform pilot & rdquo; and the first batch of designated & ldquo pilot production enterprises in the first batch of Chinese medicine regulators & rdquo;，Tianjiang Pharmaceutical is one of the only 6 pharmaceutical companies currently approved by the production of Chinese medicine formulas，​​The compound growth rate of this segment has reached 50%in the past 5 years。

 

Although the relevant countries will hold a meeting to discuss the release of the pilot qualification of the pilot particles of Chinese medicine formulas in the near future，6 pharmaceutical companies are expected to be broken，Danjiang Pharmaceutical ’s production capacity and product foundation that has gathered many years still has great favors in national medicine。

 

It is worth noting that it is，China Chinese Medicine announced on January 8 to acquire about 40.52%of Tianjiang Pharmaceuticals at the cost of up to 4.1 billion yuan，Chinese medicine on the 27th of the month increased the cost of acquisition in order to acquire 81.48%equity stake online sports bettingof Tianjiang Pharmaceutical，Stake Sports BettingA purpose of reaching the holding。

 

It is reported，After the two parties are completed here,，Chinese medicine will give full play to their respective advantages，and choose to maintain the existing management team，Keep the independence of Tianjiang operating。

 

Current，Sinopharm Group owns 11 wholly -owned or holding subsidiaries，and have Chinese medicine holding、Chinese medicine shares、The consistency of Chinese medicine、Tiantan Biological、Modern Pharmaceutical、China Chinese Medicine 6 listed companies as supporting industrial mergers and acquisitions platforms，The hotspot of the closing industry is undoubtedly the core idea。

 

& ldquo; With the acquisition of the Chinese medicine particles field, the next city，Chinese medicine also stood on the same running line with China Resources Group, China Resources Group,，Competition of industrial resources has also entered a new stage。& rdquo; Senior person in the pharmaceutical industry said to the 21st Century Business Herald。